We have analyzed frequent naturally occurring variants in the autogene FAS in two independent cystic fibrosis (CF) patient populations. Analysis of FAS expression levels from intestinal epithelial biopsies from 16 unrelated F508del-CFTR homozygotes showed a correlation between FAS intron 2 SNP rs7901656 and signals for Affymetrix GeneChip U133 Plus 2.0 probeset 204781_s_at consistent with a dominant model (P ¼ 0.0009). Genotype and haplotype analysis at six informative SNPs spanning the FAS gene locus was carried out on 37 nuclear families representing extreme clinical phenotypes that were selected from the European CF Twin and Sibling Study population of more than 300 affected sibling pairs. Case-control comparison of the haplotype composed of rs2296603-rs7901656-rs1571019 encompassing intron 2 of FAS reached significance (P ¼ 0.0246). Comparative phylogenetic analysis and functional annotation of the FAS intron 2 sequence revealed a conserved non-coding sequence surrounding rs7901656 and predicted binding sites for four transcription factors whereby the binding site of c-Rel is altered by rs7901656. Taken together, these findings from two independent CF patient cohorts indicate that allelic variants within FAS intron 2 alter FAS gene expression and that these functional variants modulate the manifestation of CF disease.
Introduction
Cystic fibrosis (CF) is a monogenic disease caused by mutations in the CF transmembrane chloride conductance regulator (CFTR) gene, resulting in deficiency or absence of functional CFTR protein at the apical cell membrane. 1 The most common disease-causing lesion F508del-CFTR is observed on about 70% of Caucasian CF chromsomes. 2 Even though about half of the CF patients are homozygous for the same CFTR mutation, the clinical course of disease was noticed to be highly variable even among F508del-CFTR homozygous individuals 3 and also within F508del-CFTR homozygous sibling pairs 4 indicating that genes other than CFTR shape the phenotype of the monogenic disease CF.
A CF patient's airways exhibit a proinflammatory phenotype even before clinical signs of bacterial or viral infection. 5 Patients are susceptible to bacterial infection by pathogenic organisms such as Pseudomonas aeruginosa, which results in neutrophil-dominated chronic inflammation. 5 The vulnerability of CF patients to infectious disease and the proinflammatory cytokine profile in CF has been based on a perturbed salt-water balance that impairs bacterial clearance, 6 on an altered transcription profile because of a prolonged NF-kB activation 7, 8 and recently, on a changed pH of intracellular organelles, which leads to a changed cell membrane composition. 9 On the cellular level, distorted apoptosis was observed in the CF condition: the intestinal epithelial cells of CF individuals showed higher susceptibility to apoptosis, 10 whereas CF respiratory epithelial cells showed delayed apoptosis in response to P. aeruginosa infection. 11 The gene FAS (also known as APO-1, CD95) on 10q24.1 encodes a member of the TNF receptor superfamily. 12 The interaction of FAS and its ligand FASLG (also known as FASL, CD95L) has a key function in the pathogenesis of various malignancies and diseases of the immune system. 12 Binding of FASLG to its receptor triggers the formation of a death-inducing signaling complex that includes FAS-associated death domain protein, caspase 8, and caspase 10. 12 The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, which leads to programmed cell death. 12 The major pathogen in CF P. aeruginosa also triggers apoptosis via the FAS/FASL system. 13 Murine models, deficient in either FAS or FASLG, are highly susceptible to P. aeruginosa. 13 In summary, the essential role of FAS in apoptosis and the increased susceptibility of FAS-deficient mice to P. aeruginosa designates FAS as a reasonable candidate gene for CF disease modulation.
We have analyzed naturally occurring frequent FAS variants for their role in the modulation of CF disease severity. Our study panel consists of 37 families with F508del homozygous sibling pairs selected from more than 300 European CF sibling pairs based on their extreme clinical phenotype. 4, 14 We have genotyped six SNPs spanning the FAS gene variants and provide evidence by functional analyses and in silico annotation that a conserved non-coding element within intron 2 of the FAS gene modulates the CF disease severity by altering FAS expression levels.
Results
The CF siblings and their parents from 37 nuclear families were genotyped at six SNPs, which span the FAS gene ( Figure 1 ). Two haplotype blocks were observed in the tested sample (Figure 2a ). We have tested for a survivor effect, which can be detected by disproportionate transmission of alleles among all nuclear families in the sibling sample (Figure 2b ).
14 A minor distortion was observed at the 5 0 end of FAS (P ¼ 0.0646 for rs1800682-rs1324551 (FAS promoter to intron 1)). In contrast, evidence of association of FAS haplotypes to CF disease severity was observed on the 3 0 end of FAS on comparison of concordant mildly (CON þ ) and concordant severely (CONÀ) affected patient pairs (Figure 2c) . Haplotype distribution at rs2296603-rs7901656-rs1571019 (intron 2 to intron 8 of FAS) was significantly different comparing CON þ and CONÀ (P ¼ 0.0246; Table 1 ). Maximal contrast for fragments defined by two adjacent markers on our map was observed in the haplotype distribution at rs2296603-rs7901656 (core haplotype in intron 2 of FAS) (P ¼ 0.0550; Table 1 ) whereby haplotype distributions on both neighboring fragments were inconspicuous comparing mildly and severely affected siblings (P ¼ 0.9795 for rs2147420-rs2296603 and P ¼ 0.3952 for rs7901656; Figure 2c ). After correction for multiple testing, the observed association was retained as a trend (P corr ¼ 0.1139; Table 1 ).
The genomic sequence of the FAS gene was analyzed on five unrelated CON þ and four unrelated CONÀ samples whereby the sequenced region contained part of promoter, exons 1-8 including flanking intron sequences (Figure 1 ). These individuals represented the most frequent haplotypes on the two FAS haplotype blocks (Figure 2a ) as outlined in Supplementary Table 3 . The genomic sequence of the entire intron 2 of FAS was ascertained for four unrelated individuals whereby each of the two frequent intron 2 core haplotypes composed of rs2296603-rs7901656 were represented in the homozygous state. No amino-acid substitution or alteration of the FAS consensus splice sites at the conserved nucleotide positions was observed among all sequenced samples. As haplotype frequency distributions were different comparing a mildly and a severely affected sibling when considering markers rs2296603-rs7901656 (core haplotype in intron 2 of FAS), we have ascertained the genomic sequence of the entire intron 2 of FAS in four unrelated samples. The contrasting haplotypes rs2296603-rs7901656 AC and GT were represented on five and three independent chromosomes, respectively. Three SNPs were identified in intron 2 by sequencing: SNP rs9658741 was found in LD with the two markers defining the intron 2 haplotypes AAC and GGT for the three markers rs2296603-rs9658741-rs7901656. SNPs rs9658742 and rs9658748 were observed on one out of five AAC and one out of three GGT chromosomes, respectively, indicating that these rare variants are phylogenetically younger than rs2296603, rs9658741 and rs7901656. To analyze whether or not FAS variants influence the mRNA levels of FAS, we have extracted the data for two probe sets annotated to represent FAS transcript levels from a global transcriptome analysis performed on rectal suction biopsies in 16 unrelated F508del homozygous who were not related to the panel of CF twins and siblings. These unrelated F508del homozygotes were genotyped at rs1800682 and rs7901656, representative of the first and second haplotype block, respectively. Expression levels determined by probe set 204780_s_at showed a minor association with the promoter SNP rs1800682 (P ¼ 0.045, Figure 4a ). At rs7901656 both probe sets 204780_s_at and 204781_s_at demonstrated strong genotype-phenotype correlation (P ¼ 0.0039 and P ¼ 0.0009; Figures 4a and b) . In other words, the genotype at SNP rs7901656 in intron 2 of FAS determined FAS expression levels.
We have analyzed the FAS intron 2 sequence for regulatory elements in order to gain insight into the molecular etiology of the observed association of FAS expression levels with an intron 2 SNP. Comparison of the entire murine and human FAS genomic sequences by a precomputed alignment visualised by VISTA 15 showed 14 blocks of conserved non-coding sequences sharing more than 75% of identity (data not shown). Four of these conserved non-coding sequences were located in FAS intron 2. The FAS intron 2 core haplotype defined by markers rs2296603 and rs7901656 harbored two CNS blocks of 100 bp each separated by 260 bp of genomic sequence whereby rs7901656 is located within the second CNS block of intron 2 ( Figure 1) . Alignment of the human CNS to the genomic sequence of 11 other vertebrates indicates that the intron 2 CNS is evolutionarily conserved (Figure 3a) , supporting a functional role of this element. The conserved CNS is partially overlapping with a region of low helical stability predicted by the webthermodyn tool 16 ( Figure 1 ). The CNS and the region of low stability contain five putative regulatory elements: a probable transcription-enhancer element, which is highly homologous to the previously identified enhancer core sequence of the human immunoglobulin g1 heavy gene HIG1 17 ( Figures 1 and 3b ) and a total of four predicted binding sites for the transcription factors STAT1a, NF-kB, NKx-2.5 and c-Rel, the latter of which overlaps rs7901656 (Figure 1 ). Allele C of rs7901656 aligns to the consensus sequence of the c-Rel binding site whereas the allele T of rs7901656 creates a mismatch.
Discussion
We have analyzed frequent naturally occurring FAS variants in two independent CF patient populations. In an association study with 6 informative FAS SNPs on 37 nuclear families with F508del-CFTR homozygous siblings we showed moderate association of an intron 2 core haplotype with disease severity (Figure 2c and Table 1 ). In contrast, correlation of FAS expression levels to FAS intron 2 genotypes was shown on 16 unrelated F508del homozygotes who were not part of the sibling study ( Figure 4) . The results of the two independent patient populations indicate consistently that FAS intron 2 contains a functional element whereby variants altering FAS gene regulation can be detected via SNP rs7901656 and haplotypes composed thereof.
Gene expression is regulated by many cis-encoded elements and the role of intronic elements has meanwhile been demonstrated by functional studies for several genes and their intragenic regulatory elements such as Tcfap2a, 18 Bmp7, 19 and Aqp5. 20 Association studies provide further evidence that variants in the non-coding sequence such as variants within the first intron of ESR1 21 and FTO 22 alter gene functionality and contribute to disease manifestation. The mechanisms by which intronic variants, by definition present in genomic DNA and pre-mRNA but not in the mature mRNA, may act at the molecular level, involve the production of more or less pre-mRNA and/or the processing of the pre-mRNA by the generation of alternatively spliced products. We have used phylogeny and other bioinformatic tools to understand the role of intron 2 of FAS. rs7901656 is located within a conserved non-coding sequence (Figures 1 and 3a) , which is taken as an indication of functional relevance. 23 A region of low helical stability, facilitating recognition by DNA binding factors, 24 overlaps with the conserved non-coding sequence (Figure 1) . Furthermore, the region of low helical stability in intron 2 FAS expression modulates CF disease severity V Kumar et al of FAS contains a sequence highly homologous to the 16-bp enhancer core sequence of the human HIG1 gene (Figures 1 and 3b) . Finally, a predicted binding site for the transcription factor c-Rel is altered by rs7901656 ( Figure 1 ). Taken together, these observations indicate that the nucleotide exchange at rs7901656 is not neutral FAS expression modulates CF disease severity V Kumar et al but instead alters FAS gene expression by itself or, more likely, in concert with neighboring functional elements residing on the same haplotype block. Correlation of FAS expression levels judged by probe set 204781_s_at with genotypes at rs7901656 suggest a dominant model whereby allele C is associated with lower FAS expression and genotype TT is associated with higher FAS expression (Figure 4) . At the FAS intron 2 core haplotype rs229603-rs7901656, an elevated frequency of allele AT was observed among concordant severely affected patient pairs whereas an elevated frequency of haplotype AC was observed among mildly affected patient pairs (Table 1) . In other words, the low-expressing allele C at rs7901656 was associated with mild CF disease whereas the high-expressing allele T at rs7901656 was associated with severe CF disease whereby the FAS expression level was deduced from epithelial cells of the gastrointestinal tract. As a consensus binding site of the transcription factor c-Rel aligns to the C-allele of rs7901656 whereas the T-allele of rs7901656 creates a mismatch (Figure 1) , the genotype-phenotype association observed upon correlation of FAS expression levels with rs7901656 genotype might be mediated at least partially through a c-Rel-dependent downregulation of FAS gene expression. Supporting this hypothesis, a c-Rel mediated transcriptional regulation of FAS transcription has been proposed recently. 25 FAS was coined as the first autogene in humans, 26 indicating that an abnormal gene function leads to autoimmune disease. A role of FAS has been inferred from elevated FAS levels for a variety of human diseases 27 ranging from cancer, 28 rheumatoid arthritis, 29 multiple sclerosis 30 to infectious disease 31 such as Helicobacter pylori gastric infections. 32 In the context of cystic fibrosis, murine models lacking either FAS or its ligand FASL have been shown to be more susceptible to P. aeruginosa infectious disease. 13 Although these mouse models are completely deficient for the activation of the FAS/FASL pathway and succumb to infection due to sepsis, a more subtle alteration of FAS resulting from an altered gene expression might lead to an altered response of FAS-expressing epithelial cells upon contact with CFtypical pathogens such as P. aeruginosa.
In conclusion, the data obtained by two independent F508del-CFTR homozygous CF patient cohorts by means of an association study on siblings with extremely contrasting phenotypes and by means of a genotypephenotype analysis on intestinal epithelial cells indicate that variants within intron 2 alter FAS gene expression and contribute to the manifestation of disease among CF patients.
Patients and methods
The study was approved by the local medical ethics committees, and informed consent was obtained from the participating control subjects, patients and parents.
European CF twin and siblings homozygous for F508del-CFTR The families enrolled for this study were selected from more than 300 patient pairs participating in the European CF Twin and Sibling Study. 4 Briefly, the disease severity of the pairs was judged on the basis of forced expiratory volume in 1 s (FEV1%), which was normalized to age by using CF population centiles (FEVPerc), and weight as a percentage of predicted weight for height (wfh%). Pairs were ranked by their disease severity and intrapair discordance. For genetic analysis, dizygous pairs exhibiting extreme disease severity were selected. From a group of 114 F508del homozygous patient pairs, 12 concordant mild pairs (CON þ ) wherein both siblings exhibit mild disease and 11 concordant severe pairs (CONÀ) wherein both siblings exhibit severe disease and 14 discordant pairs wherein one sibling is mildly affected whereas the other is severely affected and their parents were recruited. 4, 14, 33, 34 The CON þ , CONÀ and FAS expression modulates CF disease severity V Kumar et al discordant pairs were comparable with respect to age at day of recruitment and gender distribution.
14 Unrelated F508del-CFTR homozygous CF patients analyzed for FAS expression Sixteen F508del-CFTR homozygous unrelated patients from the local CF clinic were recruited to study the global transcriptome in rectal suction biopsies (van Barneveld et al., unpublished data). Total RNA was isolated from rectal suction biopsies using the RNeasy kit (Qiagen Corp, Hilden, Germany) and quality was determined by gel electrophoresis. cDNA was synthesized from total RNA and hybridized on the Affymetrix Chips (GeneChipHuman Genome U133 Plus 2.0 Array, Affymetrix, Santa Clara, CA, USA) according to the protocol from Affymetrix Manual (version 700217 rev 3). The expression data were normalized for chips and evaluated using Affymetrix Microarray Suite v5.1 software. Data for probe sets 204780_s_at and 204781_s_at, both annotated to represent FAS expression levels, were incorporated into this study.
SNP selection
SNPs located within or around FAS were selected from NCBI dbSNP database and tested for informativity by genotyping 10 DNA samples from unrelated healthy volunteer's blood. SNPs for which both homozygous and heterozygous genotypes were observed among the control samples were judged to be informative and selected for further analysis on the CF Twin and Sibling cohort.
Genotyping
Genotyping of all SNPs was performed by using a multiwell PCR-RFLP method (see Supplement for details). Genomic DNA was amplified by PCR and PCR products were digested with the appropriate restriction enzyme to discriminate between both alleles. Digested products were analyzed by electrophoresis. Reaction parameters are found in the Supplementary Table 1 .
FAS genomic resequencing
The FAS promoter region, coding region (exon 1 to exon 8) and complete intron 2 were amplified using the Failsafe PCR System (EPICENTRE Technologies, Madison, WI, USA) according to the manufacturer's instructions. Sequencing was performed at Qiagen employing the terminal primers and a set of internal primers for amplification of targets (Supplementary Table 2 ). Sequencing results were analyzed by aligning both 5 0 primer read as well as 3 0 primer read of a fragment against reference sequence using the software 'CodonCode Aligner' (CodonCode Corporation, Dedham, MA, USA).
In silico analysis The sequence aligning tool VISTA 15 (Visualization Tools for Alignments; AltaVistaGenomeBrowser) was employed to predict conserved non-coding sequences in FAS by comparing the FAS genomic sequence of both human and mouse. BLASTN (NCBI) was used to retrieve FAS intron 2 sequences from other organisms. Sequences showing at least 70% similarity to the human CNS were aligned with ClustalW2 multiple aligner 35 and visualized using the Jalview Java alignment editor. 36 Helical stability of FAS genomic sequence was predicted by the program Webthermodyn. 17 The program NSITEM at www.softberry.com was used to search for conserved functional motifs within the CNS. Possible transcription factor binding sites in intron 2 of FAS were predicted using P-Match. 37 
Statistics
Nuclear families were analyzed with the Monte Carlo simulation-based association test described by Knapp and Becker, 38 which can be viewed as an extension of the transmission disequilibrium test 39 to both nuclear families with more than one affected child and to haplotypes. All computations, that is, the extended transmission disequilibrium test, and the case-control comparisons, were carried out using the FAMHAP software package.
Transmissions/nontransmissions were considered in the joint sample of all nuclear families, as only affected sibling pairs for which both siblings survived at least until the age of 7 years when lung function measurements can reliably be performed were enrolled and a preferential transmission of alleles yields evidence for a mechanism which modifies the prognosis for survival of CF patients in utero and early postnatal life.
14 Second, we compared the sample of CON þ siblings to the sample of CONÀ siblings, employing the phenotypic contrast to identify modifiers for CF disease severity. 14 Correlation of FAS SNP genotypes to the transcriptional levels of FAS was done by the Mann-Whitney U-test.
